Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans.

Poetsch JH, Dahlke C, Zinser ME, Kasonta R, Lunemann S, Rechtien A, Ly ML, Stubbe HC, Krähling V, Biedenkopf N, Eickmann M, Fehling SK, Olearo F, Strecker T, Sharma P, Lang KS, Lohse AW, Schmiedel S, Becker S; VSV-Ebola Consortium (VEBCON) , Addo MM.

J Infect Dis. 2019 Jan 29;219(4):556-561. doi: 10.1093/infdis/jiy565.

2.

The Ebola Virus Nucleoprotein Recruits the Host PP2A-B56 Phosphatase to Activate Transcriptional Support Activity of VP30.

Kruse T, Biedenkopf N, Hertz EPT, Dietzel E, Stalmann G, López-Méndez B, Davey NE, Nilsson J, Becker S.

Mol Cell. 2018 Jan 4;69(1):136-145.e6. doi: 10.1016/j.molcel.2017.11.034. Epub 2017 Dec 28.

3.

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial.

Agnandji ST, Fernandes JF, Bache EB, Obiang Mba RM, Brosnahan JS, Kabwende L, Pitzinger P, Staarink P, Massinga-Loembe M, Krähling V, Biedenkopf N, Fehling SK, Strecker T, Clark DJ, Staines HM, Hooper JW, Silvera P, Moorthy V, Kieny MP, Adegnika AA, Grobusch MP, Becker S, Ramharter M, Mordmüller B, Lell B; VEBCON Consortium, Krishna S, Kremsner PG.

PLoS Med. 2017 Oct 6;14(10):e1002402. doi: 10.1371/journal.pmed.1002402. eCollection 2017 Oct.

4.

Dynamic phosphorylation of Ebola virus VP30 in NP-induced inclusion bodies.

Lier C, Becker S, Biedenkopf N.

Virology. 2017 Dec;512:39-47. doi: 10.1016/j.virol.2017.09.006. Epub 2017 Sep 13.

5.

From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein.

Hempel F, Maurer M, Brockmann B, Mayer C, Biedenkopf N, Kelterbaum A, Becker S, Maier UG.

Microb Cell Fact. 2017 Jul 27;16(1):131. doi: 10.1186/s12934-017-0745-2.

6.

Modeling the Ebolavirus Life Cycle with Transcription and Replication-Competent Viruslike Particle Assays.

Biedenkopf N, Hoenen T.

Methods Mol Biol. 2017;1628:119-131. doi: 10.1007/978-1-4939-7116-9_9.

PMID:
28573615
7.

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.

Dahlke C, Kasonta R, Lunemann S, Krähling V, Zinser ME, Biedenkopf N, Fehling SK, Ly ML, Rechtien A, Stubbe HC, Olearo F, Borregaard S, Jambrecina A, Stahl F, Strecker T, Eickmann M, Lütgehetmann M, Spohn M, Schmiedel S, Lohse AW, Becker S, Addo MM; VEBCON Consortium.

EBioMedicine. 2017 May;19:107-118. doi: 10.1016/j.ebiom.2017.03.045. Epub 2017 Apr 5.

8.

The natural compound silvestrol is a potent inhibitor of Ebola virus replication.

Biedenkopf N, Lange-Grünweller K, Schulte FW, Weißer A, Müller C, Becker D, Becker S, Hartmann RK, Grünweller A.

Antiviral Res. 2017 Jan;137:76-81. doi: 10.1016/j.antiviral.2016.11.011. Epub 2016 Nov 15.

PMID:
27864075
9.

Complete Genome Sequence of an Ebola Virus Isolate Imported from Sierra Leone to Germany Determined by Circle Sequencing.

Mengel JP, Lissin A, Biedenkopf N, Schultze T, Mannala GK, Schudt G, Kann G, Wolf T, Eickmann M, Becker S, Cemic F, Hain T.

Genome Announc. 2016 Oct 6;4(5). pii: e01011-16. doi: 10.1128/genomeA.01011-16.

10.

Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.

Henß L, Beck S, Weidner T, Biedenkopf N, Sliva K, Weber C, Becker S, Schnierle BS.

Virol J. 2016 Aug 31;13:149. doi: 10.1186/s12985-016-0607-2.

11.

RNA binding specificity of Ebola virus transcription factor VP30.

Schlereth J, Grünweller A, Biedenkopf N, Becker S, Hartmann RK.

RNA Biol. 2016 Sep;13(9):783-98. doi: 10.1080/15476286.2016.1194160. Epub 2016 Jun 17.

12.

RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.

Biedenkopf N, Schlereth J, Grünweller A, Becker S, Hartmann RK.

J Virol. 2016 Jul 27;90(16):7481-7496. doi: 10.1128/JVI.00271-16. Print 2016 Aug 15.

13.

Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.

Biedenkopf N, Lier C, Becker S.

J Virol. 2016 Apr 29;90(10):4914-4925. doi: 10.1128/JVI.03257-15. Print 2016 May 15.

14.

Transport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell Imaging Analysis of Ebolavirus-Infected Cells.

Schudt G, Dolnik O, Kolesnikova L, Biedenkopf N, Herwig A, Becker S.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S160-6. doi: 10.1093/infdis/jiv083. Epub 2015 Jun 2.

PMID:
26038396
15.

Analysis of Ebola Virus Entry Into Macrophages.

Dahlmann F, Biedenkopf N, Babler A, Jahnen-Dechent W, Karsten CB, Gnirß K, Schneider H, Wrensch F, O'Callaghan CA, Bertram S, Herrler G, Becker S, Pöhlmann S, Hofmann-Winkler H.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S247-57. doi: 10.1093/infdis/jiv140. Epub 2015 Apr 14.

16.

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer JA, Kraehling V, Kasonta R, Adegnika AA, Altfeld M, Auderset F, Bache EB, Biedenkopf N, Borregaard S, Brosnahan JS, Burrow R, Combescure C, Desmeules J, Eickmann M, Fehling SK, Finckh A, Goncalves AR, Grobusch MP, Hooper J, Jambrecina A, Kabwende AL, Kaya G, Kimani D, Lell B, Lemaître B, Lohse AW, Massinga-Loembe M, Matthey A, Mordmüller B, Nolting A, Ogwang C, Ramharter M, Schmidt-Chanasit J, Schmiedel S, Silvera P, Stahl FR, Staines HM, Strecker T, Stubbe HC, Tsofa B, Zaki S, Fast P, Moorthy V, Kaiser L, Krishna S, Becker S, Kieny MP, Bejon P, Kremsner PG, Addo MM, Siegrist CA.

N Engl J Med. 2016 Apr 28;374(17):1647-60. doi: 10.1056/NEJMoa1502924. Epub 2015 Apr 1.

17.

Marburg biosafety and biosecurity scale (MBBS): a framework for risk assessment and risk communication.

Dickmann P, Apfel F, Biedenkopf N, Eickmann M, Becker S.

Health Secur. 2015 Mar-Apr;13(2):88-95. Epub 2015 Mar 20.

PMID:
25813975
18.

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

Ewer K, Rampling T, Venkatraman N, Bowyer G, Wright D, Lambe T, Imoukhuede EB, Payne R, Fehling SK, Strecker T, Biedenkopf N, Krähling V, Tully CM, Edwards NJ, Bentley EM, Samuel D, Labbé G, Jin J, Gibani M, Minhinnick A, Wilkie M, Poulton I, Lella N, Roberts R, Hartnell F, Bliss C, Sierra-Davidson K, Powlson J, Berrie E, Tedder R, Roman F, De Ryck I, Nicosia A, Sullivan NJ, Stanley DA, Mbaya OT, Ledgerwood JE, Schwartz RM, Siani L, Colloca S, Folgori A, Di Marco S, Cortese R, Wright E, Becker S, Graham BS, Koup RA, Levine MM, Volkmann A, Chaplin P, Pollard AJ, Draper SJ, Ballou WR, Lawrie A, Gilbert SC, Hill AV.

N Engl J Med. 2016 Apr 28;374(17):1635-46. doi: 10.1056/NEJMoa1411627. Epub 2015 Jan 28.

19.

Risk communication and crisis communication in infectious disease outbreaks in Germany: what is being done, and what needs to be done.

Dickmann P, Biedenkopf N, Keeping S, Eickmann M, Becker S.

Disaster Med Public Health Prep. 2014 Jun;8(3):206-11. doi: 10.1017/dmp.2014.36. Epub 2014 May 7.

PMID:
24804970
20.

Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication.

Biedenkopf N, Hartlieb B, Hoenen T, Becker S.

J Biol Chem. 2013 Apr 19;288(16):11165-74. doi: 10.1074/jbc.M113.461285. Epub 2013 Mar 14.

21.

Phosphorylation of Marburg virus NP region II modulates viral RNA synthesis.

DiCarlo A, Biedenkopf N, Hartlieb B, Klussmeier A, Becker S.

J Infect Dis. 2011 Nov;204 Suppl 3:S927-33. doi: 10.1093/infdis/jir319.

PMID:
21987771
22.

Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis.

Aleksandrowicz P, Marzi A, Biedenkopf N, Beimforde N, Becker S, Hoenen T, Feldmann H, Schnittler HJ.

J Infect Dis. 2011 Nov;204 Suppl 3:S957-67. doi: 10.1093/infdis/jir326.

23.

Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription.

Hoenen T, Biedenkopf N, Zielecki F, Jung S, Groseth A, Feldmann H, Becker S.

J Virol. 2010 Jul;84(14):7053-63. doi: 10.1128/JVI.00737-10. Epub 2010 May 12.

24.

Role of Ebola virus VP30 in transcription reinitiation.

Martínez MJ, Biedenkopf N, Volchkova V, Hartlieb B, Alazard-Dany N, Reynard O, Becker S, Volchkov V.

J Virol. 2008 Dec;82(24):12569-73. doi: 10.1128/JVI.01395-08. Epub 2008 Oct 1.

Supplemental Content

Loading ...
Support Center